About Pfanstiehl
Pfanstiehl is a company based in Waukegan (United States) founded in 1919 was acquired by Med Opportunity Partners in April 2013.. Pfanstiehl has raised $6.7 million across 1 funding round from investors including Fidus Investment and Med Opportunity Partners. Pfanstiehl offers products and services including Sucrose, Trehalose, L-Arginine, and Custom API Manufacturing. Pfanstiehl operates in a competitive market with competitors including Colorcon, SPI Pharma, Scope Ingredients, Meggle Pharma and Crest Cellulose, among others.
- Headquarter Waukegan, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Pfanstiehl, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$6.7 M (USD)
in 1 rounds
-
Latest Funding Round
$6.7 M (USD), Series A
Jun 01, 2013
-
Investors
Fidus Investment
& 1 more
-
Employee Count
Employee Count
-
Acquired by
Med Opportunity Partners
(Apr 01, 2013)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Pfanstiehl
Pfanstiehl offers a comprehensive portfolio of products and services, including Sucrose, Trehalose, L-Arginine, and Custom API Manufacturing. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
High-purity stabilizer for vaccines and biologics.
Used for protein aggregation reduction in formulations.
Aids in viscosity reduction for high-concentration biologics.
Provides tailored manufacturing for pharmaceutical needs.
Unlock access to complete
Funding Insights of Pfanstiehl
Pfanstiehl has successfully raised a total of $6.7M through 1 strategic funding round. The most recent funding activity was a Series A round of $6.7 million completed in June 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $6.7M
-
First Round
First Round
(01 Jun 2013)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2013 | Amount | Series A - Pfanstiehl | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Pfanstiehl
Pfanstiehl has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Fidus Investment and Med Opportunity Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
PE firm investing in the US
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Pfanstiehl
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Pfanstiehl
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Pfanstiehl Comparisons
Competitors of Pfanstiehl
Pfanstiehl operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Colorcon, SPI Pharma, Scope Ingredients, Meggle Pharma and Crest Cellulose, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of specialty excipients and corporate-backed venture capital fund focused on healthcare startups
|
|
| domain | founded_year | HQ Location |
Excipient products and formulations are manufactured for pharmaceutical uses.
|
|
| domain | founded_year | HQ Location |
Formulations, warehousing, and logistics services for pharmaceuticals are provided.
|
|
| domain | founded_year | HQ Location |
Develops and manufactures pharmaceutical excipients for the industry.
|
|
| domain | founded_year | HQ Location |
Pharmaceutical excipients and food ingredients are developed and manufactured.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Pfanstiehl
When was Pfanstiehl founded?
Pfanstiehl was founded in 1919 and raised its 1st funding round 94 years after it was founded.
Where is Pfanstiehl located?
Pfanstiehl is headquartered in Waukegan, United States. It is registered at Waukegan, Illinois, United States.
Is Pfanstiehl a funded company?
Pfanstiehl is a funded company, having raised a total of $6.7M across 1 funding round to date. The company's 1st funding round was a Series A of $6.7M, raised on Jun 01, 2013.
What does Pfanstiehl do?
Founded in 1919, Pfanstiehl operates as a CDMO in the pharmaceutical and biopharmaceutical sectors from Waukegan, United States. Injectable formulation ingredients, pharmaceutical intermediates, and APIs are developed and produced in quantities from grams to multi-tons. GMP services encompass API and HPAPI manufacturing, advanced intermediates, potent compounds, linker-toxins for ADCs, and nucleoside chemistry. Biopharma offerings include carbohydrate chemistry, protein stabilizers, parenteral excipients, bioprocessing components, solubilizers, vaccine stabilizers, and lyoprotectants.
Who are the top competitors of Pfanstiehl?
Pfanstiehl's top competitors include Colorcon, DFE Pharma and Crest Cellulose.
What products or services does Pfanstiehl offer?
Pfanstiehl offers Sucrose, Trehalose, L-Arginine, and Custom API Manufacturing.
Who are Pfanstiehl's investors?
Pfanstiehl has 2 investors. Key investors include Fidus Investment, and Med Opportunity Partners.